LexaGene Holdings Inc.
LexaGene Holdings Inc. (LXXGF) Revenue
Annual & quarterly revenue history · segment & region breakdown
LXXGF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsLexaGene Holdings Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income LexaGene Holdings Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
LexaGene Holdings Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from LexaGene Holdings Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LXXGF revenue · 4 questionsLXXGF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · LexaGene Holdings Inc. SEC filings · GAAP · LexaGene Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026